Market Place
Sourcing Support
ProPhase Labs Showcases 2025 Results, Crown Platform
15 Apr 2026 //
GLOBENEWSWIRE
Prophase Labs Advances Crown Medical Collections Activity
17 Mar 2026 //
GLOBENEWSWIRE
ProPhase Labs Provides Crown Medical Collections Update
26 Jan 2026 //
GLOBENEWSWIRE
Prophase Labs To Unveil Q3 2025 Financial Results On Nov 19
18 Nov 2025 //
GLOBENEWSWIRE
Prophase Labs Partners With Redchip For Investor Relations Effort
28 Oct 2025 //
GLOBENEWSWIRE
Prophase Labs To Present At The 2025 Thinkequity Conference
24 Oct 2025 //
GLOBENEWSWIRE
Prophase Labs Validates Be-Smart Esophageal Cancer Test
22 Oct 2025 //
GLOBENEWSWIRE
Prophase Labs Completes Key Step In $50m Crown Medical
23 Sep 2025 //
GLOBENEWSWIRE
Prophase Continues Its Exploration Of A Crypto Treasury Strategy
22 Sep 2025 //
GLOBENEWSWIRE
ProPhase Holders 75%+ Approve All Proposals at Sept 9 Meeting
12 Sep 2025 //
GLOBENEWSWIRE
ProPhase Labs Files Proxy, Sets New Meeting Date
19 Aug 2025 //
GLOBENEWSWIRE
ProPhase Labs Presents Q2 2025 Financial Results on Aug 13
11 Aug 2025 //
GLOBENEWSWIRE
ProPhase Labs Calls Shareholder Meeting, Files Proxy Statement
29 Jul 2025 //
GLOBENEWSWIRE
ProPhase Labs Announces Q1 2025 Financial Results
20 May 2025 //
GLOBENEWSWIRE
ProPhase Labs to Present Q1 2025 Financial Results on May 20
13 May 2025 //
GLOBENEWSWIRE
ProPhase Labs Announces 2024 Year-End Financial Results
31 Mar 2025 //
GLOBENEWSWIRE
ProPhase Labs to Present 2024 Financial Results on March 31, 2025
27 Mar 2025 //
GLOBENEWSWIRE
ProPhase Labs to Present at Investor Summit Virtual on March 11
07 Mar 2025 //
GLOBENEWSWIRE
ProPhase Targets $50M In Cash Recovery From COVID-19 Receivables
20 Feb 2025 //
GLOBENEWSWIRE
ProPhase Labs Closes $23.6M Sale Of Pharmaloz Manufacturing
22 Jan 2025 //
GLOBENEWSWIRE
ProPhase Labs Secures Private Equity, Nears Lozenge Deal
11 Dec 2024 //
GLOBENEWSWIRE
ProPhase Labs Reports Financial Results for Q3 2024
13 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Closing of Public Offering of Common Stock
12 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs to Present Q3 2024 Financials on Nov 13
11 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Pricing of Public Offering of Common Stock
07 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Proposed Public Offering of Common Stock
07 Nov 2024 //
GLOBENEWSWIRE
ProPhase Lab Announces Pricing of Public Offering of Common Stock
07 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs Launches DNA Complete® for Direct-to-Consumer Testing
04 Nov 2024 //
GLOBENEWSWIRE
ProPhase Labs Updates On Strategic Initiatives And Liquidity Events
17 Oct 2024 //
GLOBENEWSWIRE
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
19 Aug 2024 //
GLOBENEWSWIRE
ProPhase Labs Partners With Forward Healthcare For BE-Smart Test
13 Aug 2024 //
GLOBENEWSWIRE
ProPhase Labs Q1 2024 Results, Progress On Strategic Initiatives
09 May 2024 //
GLOBENEWSWIRE
ProPhase Labs Q1 2024 Financials, Progress On Strategic Initiatives
09 May 2024 //
GLOBENEWSWIRE
ProPhase Labs To Present At Planet MicroCap Showcase: VEGAS 2024 On May 1
25 Apr 2024 //
GLOBENEWSWIRE
ProPhase Labs Unveils Project ZenQ-AI
16 Apr 2024 //
GLOBENEWSWIRE
ProPhase Labs Launches BE-Smart Test to Transform Esophageal Cancer Detection
10 Apr 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2024 //
GLOBENEWSWIRE
ProPhase Announces Progress in BE-Smart Esophageal Cancer Test Development
20 Feb 2024 //
GLOBENEWSWIRE
ProPhase Ushers in Genomics Era with Jason Karkus at the Helm of Nebula
30 Jan 2024 //
GLOBENEWSWIRE
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
04 Jan 2024 //
GLOBENEWSWIRE
ProPhase Labs Announces Financial Results for Months Ended September 30, 2023
09 Nov 2023 //
GLOBENEWSWIRE
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference
02 Nov 2023 //
GLOBENEWSWIRE
